CD79B Gene Agammaglobulinemia Type 6 Autosomal Recessive NGS Genetic DNA Test
Comprehensive Genetic Testing for Immune System Disorders
The CD79B Gene Agammaglobulinemia Type 6 Autosomal Recessive NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for primary immunodeficiency disorders. This advanced genetic analysis specifically targets mutations in the CD79B gene, which plays a critical role in B-cell development and antibody production. Utilizing state-of-the-art next-generation sequencing technology, our test provides unparalleled accuracy in detecting genetic variants associated with agammaglobulinemia type 6.
What This Test Measures and Detects
Our comprehensive NGS-based test examines the complete coding region of the CD79B gene to identify:
- Point mutations and single nucleotide variants
- Insertions and deletions affecting gene function
- Autosomal recessive inheritance patterns
- Pathogenic variants disrupting B-cell receptor signaling
- Genetic markers associated with impaired antibody production
Who Should Consider This Test
This genetic test is particularly recommended for individuals experiencing:
- Recurrent bacterial infections, especially respiratory and gastrointestinal
- Persistent low levels of immunoglobulins (IgG, IgA, IgM)
- Family history of primary immunodeficiency disorders
- Unexplained failure to thrive in infancy or childhood
- Autoimmune manifestations alongside immune deficiency
- Consanguineous family background with immune disorders
Clinical Benefits of Genetic Testing
Undergoing the CD79B gene test provides numerous clinical advantages:
- Accurate diagnosis of agammaglobulinemia type 6
- Personalized treatment strategies including immunoglobulin replacement therapy
- Family planning guidance and genetic counseling
- Early intervention to prevent serious infections
- Improved quality of life through targeted medical management
- Reduced healthcare costs by preventing complications
Understanding Your Test Results
Our comprehensive genetic report includes detailed interpretation of your results:
- Positive Result: Identifies pathogenic variants in CD79B gene confirming diagnosis of agammaglobulinemia type 6
- Negative Result: No disease-causing mutations detected in CD79B gene
- Variant of Uncertain Significance: Genetic changes with unclear clinical impact requiring further evaluation
- Carrier Status: Identification of individuals carrying one copy of mutated gene
Test Pricing Information
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly offer comprehensive genetic testing services across the United States with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.
Take Control of Your Health Today
Don’t let uncertainty about your immune health continue. Our CD79B Gene Agammaglobulinemia Type 6 Autosomal Recessive NGS Genetic DNA Test provides the clarity you need for proper diagnosis and treatment. With results available in 3-4 weeks and multiple sample collection options including blood, extracted DNA, or blood spots on FTA cards, getting tested has never been more convenient.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our expert genetic counselors are available to discuss your family history, create a pedigree chart, and guide you through the testing process.
